Demopulos, Gregory A.,Schwaeble, Hans-Wilhelm,Dudler, Thomas,Tjoelker, Larry
申请号：
AU2020201633
公开号：
AU2020201633A1
申请日:
2020.03.05
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020201633A120200319.pdf#####1002944375 Abstract In one aspect, the present invention provides methods for preventing, treating, reverting and/or delaying angiogenesis in a mammalian subject suffering from, or at risk for developing, an angiogenesis-dependent disease or condition, comprising administering to the subject an amount of a MASP-2 inhibitory agent effective to inhibit angiogenesis. In some embodiments of these aspects of the invention, the MASP-2 inhibitory agent is a MASP-2 antibody or fragment thereof.
